Clinicaltrials.gov is great for finding a certain clinical trial and studies. The database has some problems though such as for-profit clinics misusing it.
Wake Research are dedicated to providing national institutes with the highest quality research studies to help make informed decisions about the future of medicine. We conduct studies to gather preliminary data around a variety of healthcare protocols, including experimental drug studies and cancer ...
Preferred roles in treatment decision making among patients with cancer: a pooled analysis of studies using the Control Preferences Scale. Am J Manag Care. 2010;16(9):688-696.PubMedGoogle Scholar 18. Sudore RL, Knight SJ, McMahan RD, et al. A novel website to prepare diverse older ...
Wake Research are dedicated to providing national institutes with the highest quality research studies to help make informed decisions about the future of medicine. We conduct studies to gather preliminary data around a variety of healthcare protocols, including experimental drug studies and cancer ...
Wake Research are dedicated to providing national institutes with the highest quality research studies to help make informed decisions about the future of medicine. We conduct studies to gather preliminary data around a variety of healthcare protocols, including experimental drug studies and cancer ...
This cluster randomized trial evaluates the effect of a single prostate-specific antigen (PSA) screening test on 10-year prostate cancer–specific
Significant disparities continue to exist in the HIV care continuum, whereby Hispanic and Black people living with HIV (PLWH) are less likely to achieve viral suppression compared to their White counterparts. Studies have shown that intervention approach
Treatment efficacy of androgen deprivation therapy with radical prostatectomy for intermediate- to high-risk prostate cancer is less well-studied. The NEAR trial is a single-arm, phase II investigation of neoadjuvant apalutamide monotherapy and radical p
Tumor mutational burden (TMB) is being explored as a predictive biomarker for cancer immunotherapy outcomes in non-small cell lung cancer. BFAST (NCT03178552)—an open-label, global, multicohort trial—evaluated the safety and efficacy of first-line targeted therapies or immunotherapy in patients wi...
Further studies are needed to understand interactions between CCP, corticosteroids, and remdesivir.We found no associations between clinical outcome and CCP EC50 or neutralizing titer, or participant SARS-CoV-2 serostatus. Less than 15% of our cohort had cancer or other immunosuppressing conditions ...